Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MOHIT KHERA and MOHIT KHERA.
MOHIT KHERA
Connection Strength
71.898
MOHIT KHERA
  1. Sexual Health. J Urol. 2026 Feb 19; 101097JU0000000000004972.
    View in: PubMed
    Score: 0.992
  2. Sexual Health. J Urol. 2026 Mar; 215(3):356-357.
    View in: PubMed
    Score: 0.990
  3. Sexual Health. J Urol. 2026 Jan 05; 101097JU0000000000004906.
    View in: PubMed
    Score: 0.984
  4. A new kind of prescription: how sexual health impacts total wellness. J Sex Med. 2025 Nov 02; 22(11):2079-2081.
    View in: PubMed
    Score: 0.972
  5. Sexual Health. J Urol. 2026 Jan; 215(1):101-102.
    View in: PubMed
    Score: 0.967
  6. Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024). Sex Med Rev. 2025 Oct 04; 13(4):548-573.
    View in: PubMed
    Score: 0.966
  7. Trends in blood-based metabolic and cardiovascular risk profiles in men during treatment for testosterone deficiency: a longitudinal, retrospective cohort study. J Sex Med. 2025 Sep 04; 22(9):1564-1571.
    View in: PubMed
    Score: 0.961
  8. Sexual Health. J Urol. 2025 Dec; 214(6):666-668.
    View in: PubMed
    Score: 0.961
  9. Sexual Health. J Urol. 2025 Nov; 214(5):550-552.
    View in: PubMed
    Score: 0.955
  10. Long-term testosterone pellet insertion in women with low libido shows no evidence of erythrocytosis and a minimal side effect profile. Transl Androl Urol. 2025 Jul 30; 14(7):1842-1848.
    View in: PubMed
    Score: 0.954
  11. Testosterone deficiency and treatments: common misconceptions and practical guidance for patient care. Sex Med Rev. 2025 Jul 03; 13(3):373-380.
    View in: PubMed
    Score: 0.950
  12. Transcutaneous electrical neural stimulation in patients with erectile dysfunction: a single arm pilot study. J Sex Med. 2025 05 10; 22(5):971-972.
    View in: PubMed
    Score: 0.940
  13. Exploring the Impact of a Masters of Business Administration on Urologists' Careers. Urology. 2025 Sep; 203:42-46.
    View in: PubMed
    Score: 0.934
  14. Testosterone replacement therapy in men on active surveillance for prostate cancer. J Sex Med. 2025 04 08; 22(3):432-438.
    View in: PubMed
    Score: 0.934
  15. Video discharge instructions increase patient understanding for office-based procedures: a randomized controlled study. Transl Androl Urol. 2025 Mar 30; 14(3):678-684.
    View in: PubMed
    Score: 0.932
  16. Newer formulations of oral testosterone undecanoate: development and liver side effects. Sex Med Rev. 2025 Jan 31; 13(1):33-40.
    View in: PubMed
    Score: 0.922
  17. Erectile dysfunction as a holistic indicator of well-being: a narrative review. Sex Med Rev. 2025 Jan 31; 13(1):11-19.
    View in: PubMed
    Score: 0.922
  18. Editorial Comment on "Rethinking Low Testosterone in Older Men: Association With Obesity Rather Than Aging". Urology. 2025 Apr; 198:213-214.
    View in: PubMed
    Score: 0.922
  19. Sexspan: a comprehensive framework for sustaining lifelong sexual health and vitality. J Sex Med. 2025 01 03; 22(1):4-6.
    View in: PubMed
    Score: 0.917
  20. Regenerative therapies for erectile dysfunction: a systematic review, Bayesian network meta-analysis, and meta-regression. J Sex Med. 2024 12 01; 21(12):1152-1158.
    View in: PubMed
    Score: 0.912
  21. Development of a new Peyronie's disease self-assessment screening app. Transl Androl Urol. 2024 Nov 30; 13(11):2617-2624.
    View in: PubMed
    Score: 0.911
  22. Lessons learned from the Sexual Medicine Society of North America fellowship bootcamp. J Sex Med. 2024 09 28; 21(10):961-966.
    View in: PubMed
    Score: 0.901
  23. Advancements in ectopic reservoir placement for inflatable penile prostheses. Sex Med Rev. 2024 09 25; 12(4):770-781.
    View in: PubMed
    Score: 0.900
  24. Safety and efficacy of enclomiphene and clomiphene for hypogonadal men. Transl Androl Urol. 2024 Sep 30; 13(9):1984-1990.
    View in: PubMed
    Score: 0.900
  25. Lessons learned from the TRAVERSE trial. J Sex Med. 2024 09 03; 21(9):746-748.
    View in: PubMed
    Score: 0.896
  26. Long-Term Satisfaction With Collagenase Clostridium Histolyticum for Peyronie's Disease: Clinical Predictors and Side Effect Profile. Urol Pract. 2025 01; 12(1):168-175.
    View in: PubMed
    Score: 0.896
  27. Sexual Medicine Society of North America (SMSNA)/American Urological Association (AUA) telemedicine and men's health white paper. J Sex Med. 2024 03 28; 21(4):318-332.
    View in: PubMed
    Score: 0.870
  28. Optimizing sexual reproductive health of men and women with cystic fibrosis: A systematic review. J Cyst Fibros. 2024 Jul; 23(4):633-638.
    View in: PubMed
    Score: 0.861
  29. First-time orgasm in a young man with lifelong anorgasmia after flibanserin use: a case report. Sex Med. 2023 Dec; 11(6):qfad066.
    View in: PubMed
    Score: 0.857
  30. Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2024 Sep; 27(3):507-519.
    View in: PubMed
    Score: 0.856
  31. Stem cell therapy for erectile dysfunction: a systematic review. Sex Med Rev. 2023 12 23; 12(1):87-93.
    View in: PubMed
    Score: 0.854
  32. Hyperbaric oxygen therapy as a treatment for erectile dysfunction: a meta-analysis. Sex Med Rev. 2023 12 23; 12(1):94-99.
    View in: PubMed
    Score: 0.854
  33. Will you go the distance? A satisfaction survey of telemedicine in sexual medicine. Sex Med. 2023 Dec; 11(6):qfad060.
    View in: PubMed
    Score: 0.853
  34. Effect of aerobic exercise on erectile function: systematic review and meta-analysis of randomized controlled trials. J Sex Med. 2023 11 30; 20(12):1369-1375.
    View in: PubMed
    Score: 0.850
  35. Implantable Penile Prosthesis for Erectile Dysfunction: Insurance Coverage in the United States. Urol Pract. 2023 09; 10(5):501-510.
    View in: PubMed
    Score: 0.834
  36. Quantifying the number of US men with erectile dysfunction who are potential candidates for penile prosthesis implantation. Sex Med. 2023 Apr; 11(2):qfad010.
    View in: PubMed
    Score: 0.815
  37. The Low Submuscular Reservoir Placement With Transfascial Fixation for Inflatable Penile Prostheses. J Sex Med. 2022 08; 19(8):1309-1312.
    View in: PubMed
    Score: 0.769
  38. Testosterone replacement therapy and cardiovascular disease. Int J Impot Res. 2022 Nov; 34(7):685-690.
    View in: PubMed
    Score: 0.746
  39. The Potential for Pharmacological Interventions for Low Sex Drive in Men. J Sex Med. 2022 02; 19(2):165-169.
    View in: PubMed
    Score: 0.745
  40. Ectopic low submuscular pressure regulating balloon placement with transfascial fixation for artificial urinary sphincter. Can J Urol. 2021 12; 28(6):10936-10940.
    View in: PubMed
    Score: 0.741
  41. Differential Gene Expression in Post-Finasteride Syndrome Patients. J Sex Med. 2021 09; 18(9):1479-1490.
    View in: PubMed
    Score: 0.720
  42. Testosterone's Role in COVID-19. J Sex Med. 2021 05; 18(5):843-848.
    View in: PubMed
    Score: 0.705
  43. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk. J Sex Med. 2021 01; 18(1):83-98.
    View in: PubMed
    Score: 0.692
  44. Controversies in Testosterone Therapy. Sex Med Rev. 2021 01; 9(1):149-159.
    View in: PubMed
    Score: 0.692
  45. Is there still a place for malleable penile implants in the United States? Wilson's Workshop #18. Int J Impot Res. 2023 Mar; 35(2):82-89.
    View in: PubMed
    Score: 0.691
  46. Hypogonadism management and cardiovascular health. Postgrad Med. 2020 Dec; 132(sup4):35-41.
    View in: PubMed
    Score: 0.685
  47. Controversies with testosterone therapy. Can J Urol. 2020 08; 27(S3):20-23.
    View in: PubMed
    Score: 0.675
  48. Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia. Transl Androl Urol. 2020 Jun; 9(3):1201-1209.
    View in: PubMed
    Score: 0.667
  49. Bipolar Androgen Therapy in Prostate Cancer (Update). J Sex Med. 2020 05; 17(5):831-834.
    View in: PubMed
    Score: 0.653
  50. A Critique of the AUA Guidelines on Testosterone Deficiency. J Sex Med. 2020 04; 17(4):561-564.
    View in: PubMed
    Score: 0.645
  51. Editorial Comment. J Urol. 2019 09; 202(3):610.
    View in: PubMed
    Score: 0.631
  52. An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress? Eur Urol Focus. 2019 Jul; 5(4):536-538.
    View in: PubMed
    Score: 0.624
  53. Effect of Body Weight on Sexual Function in Men and Women. Curr Sex Health Rep. 2019 Mar; 11(1):52-59.
    View in: PubMed
    Score: 0.607
  54. Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male. Eur Urol Focus. 2018 04; 4(3):321-323.
    View in: PubMed
    Score: 0.590
  55. The Role of Testosterone Therapy in the Setting of Prostate Cancer. Curr Urol Rep. 2018 Jun 30; 19(8):67.
    View in: PubMed
    Score: 0.584
  56. Penile Prosthesis Implantation in Patients With Peyronie's Disease: Results of the PROPPER Study Demonstrates a Decrease in Patient-Reported Depression. J Sex Med. 2018 05; 15(5):786-788.
    View in: PubMed
    Score: 0.575
  57. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. J Sex Med. 2018 02; 15(2):148-158.
    View in: PubMed
    Score: 0.568
  58. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes. Med Clin North Am. 2018 Mar; 102(2):361-372.
    View in: PubMed
    Score: 0.562
  59. Alternatives to Testosterone Therapy: A Review. Sex Med Rev. 2018 01; 6(1):106-113.
    View in: PubMed
    Score: 0.561
  60. Testosterone therapy improves erectile function and libido in hypogonadal men. Curr Opin Urol. 2017 Nov; 27(6):511-515.
    View in: PubMed
    Score: 0.558
  61. Testosterone inhibits the growth of prostate cancer xenografts in nude mice. BMC Cancer. 2017 Sep 07; 17(1):635.
    View in: PubMed
    Score: 0.552
  62. Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies. Transl Androl Urol. 2017 Feb; 6(1):28-36.
    View in: PubMed
    Score: 0.530
  63. Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population. J Sex Med. 2017 01; 14(1):88-97.
    View in: PubMed
    Score: 0.524
  64. Testosterone therapy and prostate cancer. Transl Androl Urol. 2016 Dec; 5(6):909-920.
    View in: PubMed
    Score: 0.524
  65. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM?2015). J Sex Med. 2016 12; 13(12):1787-1804.
    View in: PubMed
    Score: 0.524
  66. Editorial Comment on "Couple-Based Psychosexual Support Following Prostate Cancer Surgery: Results of a Feasibility Pilot Randomized Control Trial". J Sex Med. 2016 08; 13(8):1243-4.
    View in: PubMed
    Score: 0.512
  67. Adult-Onset Hypogonadism. Mayo Clin Proc. 2016 07; 91(7):908-26.
    View in: PubMed
    Score: 0.508
  68. Testosterone Therapies. Urol Clin North Am. 2016 May; 43(2):185-93.
    View in: PubMed
    Score: 0.499
  69. Male hormones and men's quality of life. Curr Opin Urol. 2016 Mar; 26(2):152-7.
    View in: PubMed
    Score: 0.497
  70. Testosterone is Protective against Cardiac Disease: Pro. J Urol. 2016 04; 195(4 Pt 1):831-2.
    View in: PubMed
    Score: 0.493
  71. Changing paradigm of men's health. Indian J Urol. 2016 Jan-Mar; 32(1):5.
    View in: PubMed
    Score: 0.491
  72. The Evolution of the Inflatable Penile Prosthesis Reservoir and Surgical Placement. J Sex Med. 2015 Nov; 12 Suppl 7:464-7.
    View in: PubMed
    Score: 0.486
  73. Testosterone Replacement in Men with Treated and Untreated Prostate Cancer. Sex Med Rev. 2013 Oct; 1(3):143-149.
    View in: PubMed
    Score: 0.485
  74. Testosterone Therapy for Female Sexual Dysfunction. Sex Med Rev. 2015 Jul; 3(3):137-144.
    View in: PubMed
    Score: 0.484
  75. Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer. Asian J Androl. 2015 Sep-Oct; 17(5):807-10.
    View in: PubMed
    Score: 0.480
  76. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. J Urol. 2015 Nov; 194(5):1271-6.
    View in: PubMed
    Score: 0.471
  77. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med. 2015 May; 12(5):1105-6.
    View in: PubMed
    Score: 0.469
  78. Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis. J Sex Med. 2015 Apr; 12(4):975-84.
    View in: PubMed
    Score: 0.464
  79. Controversies in testosterone supplementation therapy. Asian J Androl. 2015 Mar-Apr; 17(2):175-6.
    View in: PubMed
    Score: 0.464
  80. RE: Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology. 2015 Jan; 156(1):L1-2.
    View in: PubMed
    Score: 0.459
  81. Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro. Asian J Androl. 2014 Nov-Dec; 16(6):864-8.
    View in: PubMed
    Score: 0.453
  82. Alternative treatment modalities for the hypogonadal patient. Curr Urol Rep. 2014 Jul; 15(7):417.
    View in: PubMed
    Score: 0.443
  83. Reply to Julia Klap and Kevin R. Loughlin's letter to the editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23. Eur Urol. 2014 Aug; 66(2):e33.
    View in: PubMed
    Score: 0.438
  84. Controversies in the treatment of male hypogonadism. Urology. 2014 Apr; 83(4):957.
    View in: PubMed
    Score: 0.435
  85. Patients with testosterone deficit syndrome and depression. Arch Esp Urol. 2013 Sep; 66(7):729-36.
    View in: PubMed
    Score: 0.418
  86. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014 Jan; 65(1):115-23.
    View in: PubMed
    Score: 0.417
  87. Nitric oxide-releasing polymeric microspheres improve diabetes-related erectile dysfunction. J Sex Med. 2013 Aug; 10(8):1915-25.
    View in: PubMed
    Score: 0.411
  88. 12-month observation of testosterone replacement effectiveness in a general population of men. Postgrad Med. 2013 Mar; 125(2):8-18.
    View in: PubMed
    Score: 0.404
  89. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44.
    View in: PubMed
    Score: 0.402
  90. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med. 2013 Feb; 10(2):562-9.
    View in: PubMed
    Score: 0.393
  91. Testosterone replacement in normal and pathologic prostate. Horm Mol Biol Clin Investig. 2012 Oct; 11(3):347-53.
    View in: PubMed
    Score: 0.392
  92. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012 Sep-Oct; 33(5):927-37.
    View in: PubMed
    Score: 0.377
  93. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). Aging Male. 2012 Mar; 15(1):14-21.
    View in: PubMed
    Score: 0.369
  94. Subcutaneous implantable testosterone pellets overcome noncompliance in adolescents with Klinefelter syndrome. J Androl. 2012 Jul-Aug; 33(4):570-3.
    View in: PubMed
    Score: 0.365
  95. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011 Nov; 8(11):3204-13.
    View in: PubMed
    Score: 0.362
  96. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory. J Urol. 2011 Sep; 186(3):1005-11.
    View in: PubMed
    Score: 0.361
  97. Erectile dysfunction. BMJ Clin Evid. 2011 Jun 29; 2011.
    View in: PubMed
    Score: 0.359
  98. Testosterone therapy in men with untreated prostate cancer. J Urol. 2011 Apr; 185(4):1256-60.
    View in: PubMed
    Score: 0.351
  99. Revision of penile prosthesis surgery after use of penile traction therapy to increase erect penile length: case report and review of the literature. J Sex Med. 2011 Feb; 8(2):607-11.
    View in: PubMed
    Score: 0.345
  100. Androgen replacement therapy after prostate cancer treatment. Curr Urol Rep. 2010 Nov; 11(6):393-9.
    View in: PubMed
    Score: 0.343
  101. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med. 2010 Nov; 7(11):3659-65.
    View in: PubMed
    Score: 0.339
  102. Testosterone replacement therapy following radical prostatectomy. J Sex Med. 2009 Apr; 6(4):1165-1170.
    View in: PubMed
    Score: 0.304
  103. Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men. J Sex Med. 2009 Mar; 6 Suppl 3:234-8.
    View in: PubMed
    Score: 0.304
  104. Evolving approach to the varicocele. Urol Clin North Am. 2008 May; 35(2):183-9, viii.
    View in: PubMed
    Score: 0.289
  105. The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am. 2007 Nov; 34(4):549-53, vi.
    View in: PubMed
    Score: 0.279
  106. The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats. BJU Int. 2007 Feb; 99(2):442-6.
    View in: PubMed
    Score: 0.265
  107. Can preoperative behavioral training reduce postprostatectomy incontinence? Nat Clin Pract Urol. 2006 Jun; 3(6):302-3.
    View in: PubMed
    Score: 0.253
  108. In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology. 2005 Jul; 66(1):208-12.
    View in: PubMed
    Score: 0.237
  109. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int. 2004 Dec; 45(7):987-93.
    View in: PubMed
    Score: 0.228
  110. Botulinum toxin type A: a novel approach to the treatment of recurrent urethral strictures. J Urol. 2004 Aug; 172(2):574-5.
    View in: PubMed
    Score: 0.223
  111. Testosterone Therapy in Adult Males with Hypogonadism. Eur Urol. 2025 Dec 24.
    View in: PubMed
    Score: 0.061
  112. Guidance on the use of oral testosterone undecanoate: background, clinical considerations, and best practices. J Sex Med. 2025 Nov 02; 22(11):1976-1977.
    View in: PubMed
    Score: 0.061
  113. Exploring the link between muscle quality and erectile dysfunction: assessing the impact of mass and strength. Sex Med Rev. 2025 Oct 04; 13(4):643-651.
    View in: PubMed
    Score: 0.060
  114. Exploring perspectives on current rules denying testosterone replacement therapy for testosterone deficient female competitive athletes: a survey study. J Sex Med. 2025 06 29; 22(7):1298-1300.
    View in: PubMed
    Score: 0.059
  115. Wearable penile devices: the TechRing. Transl Androl Urol. 2025 Jan 31; 14(1):152-157.
    View in: PubMed
    Score: 0.058
  116. Penile constriction devices: a randomized survey study to compare preferences between two medical-grade devices. J Sex Med. 2025 01 03; 22(1):43-50.
    View in: PubMed
    Score: 0.057
  117. Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism. Andrology. 2025 May; 13(4):882-893.
    View in: PubMed
    Score: 0.056
  118. Can semen analysis be utilized as a screening tool for overall health in young men? Int J Impot Res. 2025 Aug; 37(8):583-586.
    View in: PubMed
    Score: 0.055
  119. Cosmetic penile enhancement procedures: an SMSNA position statement. J Sex Med. 2024 05 28; 21(6):573-578.
    View in: PubMed
    Score: 0.055
  120. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. J Clin Endocrinol Metab. 2024 Jan 18; 109(2):569-580.
    View in: PubMed
    Score: 0.054
  121. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 12 01; 6(12):e2348692.
    View in: PubMed
    Score: 0.053
  122. Reply by Authors. Urol Pract. 2023 07; 10(4):326.
    View in: PubMed
    Score: 0.052
  123. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 07 13; 389(2):107-117.
    View in: PubMed
    Score: 0.051
  124. Increasing Role of the Advanced Practice Provider in Men's Health Clinics: An Analysis of Medicare and Commercial Claims in the United States. Urol Pract. 2023 07; 10(4):320-325.
    View in: PubMed
    Score: 0.051
  125. Oral testosterone therapy: past, present, and future. Sex Med Rev. 2023 04 03; 11(2):124-138.
    View in: PubMed
    Score: 0.051
  126. Recognizing the True Value of Testosterone Therapy in Health Care. Androg Clin Res Ther. 2022; 3(1):217-223.
    View in: PubMed
    Score: 0.050
  127. Is urgent surgical management necessary for priapism in pediatric patients with hematologic conditions? J Pediatr Urol. 2022 08; 18(4):528.e1-528.e6.
    View in: PubMed
    Score: 0.048
  128. Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007-2015. Cancer Epidemiol. 2022 08; 79:102172.
    View in: PubMed
    Score: 0.048
  129. Long-Term Survival Rates of Inflatable Penile Prostheses: Systematic Review and Meta-Analysis. Urology. 2022 08; 166:6-10.
    View in: PubMed
    Score: 0.047
  130. A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism. Andrology. 2022 05; 10(4):669-676.
    View in: PubMed
    Score: 0.047
  131. Current strategies to improve erectile function in patients undergoing radical prostatectomy - preoperative scenario. Urol Oncol. 2022 03; 40(3):72-78.
    View in: PubMed
    Score: 0.047
  132. Current strategies to improve erectile function in patients undergoing radical prostatectomy - postoperative scenario. Urol Oncol. 2022 03; 40(3):87-94.
    View in: PubMed
    Score: 0.047
  133. Current strategies to improve erectile function in patients undergoing radical prostatectomy-intraoperative scenario. Urol Oncol. 2022 03; 40(3):79-86.
    View in: PubMed
    Score: 0.047
  134. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Int J Risk Saf Med. 2022; 33(1):65-76.
    View in: PubMed
    Score: 0.047
  135. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. Am Heart J. 2022 03; 245:41-50.
    View in: PubMed
    Score: 0.046
  136. Comparative assessment of outcomes and adverse effects using two different intramuscular testosterone therapy regimens: 100?mg IM weekly or 200?mg IM biweekly. Int J Impot Res. 2022 Sep; 34(6):558-563.
    View in: PubMed
    Score: 0.045
  137. Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men. J Cardiovasc Pharmacol Ther. 2021 11; 26(6):630-637.
    View in: PubMed
    Score: 0.045
  138. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer. Cancer Causes Control. 2021 Sep; 32(9):965-976.
    View in: PubMed
    Score: 0.045
  139. Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A. Can Urol Assoc J. 2021 May; 15(5):E234-E243.
    View in: PubMed
    Score: 0.044
  140. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men. Cancer Prev Res (Phila). 2021 07; 14(7):719-728.
    View in: PubMed
    Score: 0.044
  141. The Emerging Critical Role of Telemedicine in the Urology Clinic: A Practical Guide. Sex Med Rev. 2021 04; 9(2):289-295.
    View in: PubMed
    Score: 0.044
  142. Unilateral Corporal Cavernosum Partial Thrombosis: A Challenging Presentation and Management. Urology. 2021 06; 152:12-14.
    View in: PubMed
    Score: 0.044
  143. Testosterone Therapy After Prostate Cancer Treatment: A Review of Literature. Sex Med Rev. 2021 07; 9(3):393-405.
    View in: PubMed
    Score: 0.044
  144. Is treatment of hypogonadism safe for men after a solid organ transplant? Results from a retrospective controlled cohort study. Int J Impot Res. 2022 Jan; 34(1):50-54.
    View in: PubMed
    Score: 0.043
  145. Response to Commentary on Contemporary Considerations in a Man With Low Sex Drive. J Sex Med. 2020 11; 17(11):2311.
    View in: PubMed
    Score: 0.043
  146. Novel Treatments of Erectile Dysfunction: Review of the Current Literature. Sex Med Rev. 2021 01; 9(1):123-132.
    View in: PubMed
    Score: 0.042
  147. Contemporary Considerations in the Pathophysiology of Low Sex Drive in Men. J Sex Med. 2020 06; 17(6):1049-1052.
    View in: PubMed
    Score: 0.041
  148. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database. Clin Endocrinol (Oxf). 2019 12; 91(6):885-891.
    View in: PubMed
    Score: 0.040
  149. Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers. 2019 May 30; 5(1):38.
    View in: PubMed
    Score: 0.039
  150. Erectile Dysfunction: AUA Guideline. J Urol. 2018 09; 200(3):633-641.
    View in: PubMed
    Score: 0.036
  151. Caffeine intake is not associated with serum testosterone levels in adult men: cross-sectional findings from the NHANES 1999-2004 and 2011-2012. Aging Male. 2019 Mar; 22(1):45-54.
    View in: PubMed
    Score: 0.036
  152. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk. Clin Endocrinol (Oxf). 2018 07; 89(1):3-10.
    View in: PubMed
    Score: 0.036
  153. Inflatable penile prosthesis implant length with baseline characteristic correlations: preliminary analysis of the PROPPER study. Transl Androl Urol. 2017 Dec; 6(6):1167-1174.
    View in: PubMed
    Score: 0.035
  154. Recent advances in the treatment of erectile dysfunction. Postgrad Med J. 2017 Nov; 93(1105):679-685.
    View in: PubMed
    Score: 0.034
  155. Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members. Urology. 2017 Aug; 106:87-95.
    View in: PubMed
    Score: 0.034
  156. Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):285-296.
    View in: PubMed
    Score: 0.033
  157. Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):297-315.
    View in: PubMed
    Score: 0.033
  158. Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction. J Sex Med. 2016 08; 13(8):1183-98.
    View in: PubMed
    Score: 0.032
  159. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016 Apr; 13(4):465-88.
    View in: PubMed
    Score: 0.031
  160. Diagnosing secondary hypogonadism: important consequences for fertility and reversibility. BJU Int. 2016 Apr; 117(4):552-4.
    View in: PubMed
    Score: 0.030
  161. The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data. J Urol. 2016 Feb; 195(2):427-33.
    View in: PubMed
    Score: 0.030
  162. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen. Sex Med. 2015 Sep; 3(3):165-73.
    View in: PubMed
    Score: 0.030
  163. Peyronie's Disease: AUA Guideline. J Urol. 2015 Sep; 194(3):745-53.
    View in: PubMed
    Score: 0.030
  164. The nanochannel delivery system for constant testosterone replacement therapy. J Sex Med. 2015 Jun; 12(6):1375-80.
    View in: PubMed
    Score: 0.029
  165. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015 Feb; 90(2):224-51.
    View in: PubMed
    Score: 0.029
  166. Delivering enhanced testosterone replacement therapy through nanochannels. Adv Healthc Mater. 2015 Feb 18; 4(3):446-51.
    View in: PubMed
    Score: 0.028
  167. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014 Nov; 11(11):2764-71.
    View in: PubMed
    Score: 0.028
  168. The safety of testosterone supplementation therapy in prostate cancer. Nat Rev Urol. 2014 Sep; 11(9):526-30.
    View in: PubMed
    Score: 0.028
  169. Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014 Jul; 11(7):1636-45.
    View in: PubMed
    Score: 0.027
  170. North American consensus document on infection of penile prostheses. Urology. 2013 Oct; 82(4):937-42.
    View in: PubMed
    Score: 0.026
  171. Current opinions on alternative reservoir placement for inflatable penile prosthesis among members of the Sexual Medicine Society of North America. J Sex Med. 2013 Aug; 10(8):2115-20.
    View in: PubMed
    Score: 0.026
  172. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry. Postgrad Med. 2013 Mar; 125(2):19-29.
    View in: PubMed
    Score: 0.025
  173. The treatment of hypogonadism in?men of reproductive age. Fertil Steril. 2013 Mar 01; 99(3):718-24.
    View in: PubMed
    Score: 0.025
  174. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging. 2012; 7:321-30.
    View in: PubMed
    Score: 0.024
  175. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS). Pain Med. 2012 May; 13(5):688-98.
    View in: PubMed
    Score: 0.024
  176. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(?)) insertion. J Sex Med. 2012 Feb; 9(2):594-601.
    View in: PubMed
    Score: 0.023
  177. Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocr Disord. 2011 Nov 01; 11:18.
    View in: PubMed
    Score: 0.023
  178. Favorable female sexual function is associated with patient satisfaction after inflatable penile prosthesis implantation. J Sex Med. 2011 Jul; 8(7):1996-2001.
    View in: PubMed
    Score: 0.022
  179. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency. Postgrad Med. 2011 May; 123(3):17-27.
    View in: PubMed
    Score: 0.022
  180. Reply by authors. J Urol. 2010 Jun; 183(6):2315.
    View in: PubMed
    Score: 0.021
  181. Varicocele repair in patients with nonobstructive azoospermia: a meta-analysis. J Urol. 2010 Jun; 183(6):2309-15.
    View in: PubMed
    Score: 0.021
  182. Percutaneous treatment of varicocele with microcoil embolization: comparison of treatment outcome with laparoscopic varicocelectomy. Vascular. 2009 Nov-Dec; 17 Suppl 3:S129-36.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.